Donepezil is a cholinesterase inhibitor used to improve cognition and behavior in individuals with Alzheimer’s disease. It is grouped under the following drug class(es): Psychotropic agents and QTc-prolonging agents. Its therapeutic use is listed as central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Aricept, Donaz, Donepezilum and Domepezil. Its PubChem CID is 3152.
Donepezil
| CAS No | 120014-06-4 |
|---|---|
| Molecular Formula | C24H29NO3 |
| Molecular Weight | 379.5 g/mol |
| Synonyms | 2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Donepezil is a cholinesterase inhibitor used to improve cognition and behavior in individuals with Alzheimer's disease. It is grouped under the following drug class(es): Psychotropic agents and QTc-prolonging agents.
The listed CAS number is 120014-06-4.
The listed molecular formula is C24H29NO3.
The listed molecular weight is 379.5 g/mol.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one.
The source lists Aricept, Donaz, Donepezilum and Domepezil.